ArticlePloS one2026
Research on precise segmentation model of thyroid nodules based on deep learning.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid nodules are a prevalent condition in clinical practice, typically identified via ultrasound imaging with visual assessment by physicians. However, the ambiguous features of malignant nodules, their proximity to surrounding tissues, image noise, and unclear boundaries can lead to variability in diagnostic outcomes among different practitioners. In this study, we initially employed nine established models to segment ultrasound images from two publicly available datasets, TN3K and DDTI. Evaluation metrics including IoU, F1-score, accuracy (Acc), specificity (Spec), and precision (Pre) were utilized to assess the segmentation performance of these models. The experimental results indicate that, given the current data scale, the overall segmentation performance of each model is relatively low. Analysis suggests this is primarily due to the limited number of samples in the medical imaging dataset. During training, the model struggles to fully learn the discriminative features of the lesion area. Particularly during the encoder's down-sampling stage, the feature expression ability is constrained, affecting the model's ability to accurately recognize lesion locations. To address this, we enhanced the classic model by incorporating the Residual Network ResNet34, constructing a new thyroid nodule segmentation model. The improved model demonstrated enhanced segmentation performance, with most IoU values on the TN3K dataset exceeding 0.8. However, models trained on the DDTI dataset rarely achieved high performance. Further analysis attributes this performance disparity to differences in the number of training samples. To further enhance model performance, we initialized the improved model with pre-trained ResNet34 weights from the ImageNet dataset, resulting in significant performance improvements. Notably, Res34-PAN performed best across both datasets. On the DDTI dataset, the model achieved an IoU of 0.8778, an F1-score of 0.9349, an accuracy of 0.9872, a specificity of 0.9928, and a precision of 0.9342. To further validate the model design's rationale, we conducted a systematic ablation experiment. We selected commonly used network structures for encoders and used them as the encoders for nine segmentation models, comparing performance with and without the ImageNet pre-trained weights. The results further confirmed the effectiveness of the proposed method in the thyroid nodule segmentation task.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.